Fangjin Huang
发表
B. Knudsen,
A. Gertych,
S. Shiao,
2017,
Diagnostic Pathology.
B. Berman,
A. Marchevsky,
S. Feller,
2016,
The journal of pathology. Clinical research.
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Simon G. Coetzee,
P. Nelson,
S. Freedland,
2018,
Nature Medicine.
R. Figlin,
M. Amin,
B. Knudsen,
2017,
Scientific Reports.
Hisashi Tanaka,
B. Knudsen,
Fangjin Huang,
2020
.
R. Chen,
Guofang Ding,
Fangmiao Yu,
2018,
Marine drugs.
M. Moasser,
W. Carter,
J. Lang,
2018,
Oncogene.
Tao Wu,
Fangjin Huang,
Tong Wu,
2012
.
Jian Zhang,
Hui Zeng,
Fangjin Huang,
2013,
Stem Cell Research & Therapy.
B. Leiby,
T. Visakorpi,
F. Feng,
2018,
EMBO molecular medicine.
D. Liang,
Jian Zhang,
Xiaoping Chen,
2013,
PloS one.
Hui Zeng,
Fangjin Huang,
Deng-shu Wu,
2014,
PloS one.
Arkadiusz Gertych,
Fangjin Huang,
Beatrice S. Knudsen,
2018,
Front. Immunol..
Xiaoping Chen,
Hui Zeng,
Fangjin Huang,
2013,
Cancer letters.
Hisashi Tanaka,
B. Knudsen,
Fangjin Huang,
2020,
BMC Medical Genetics.
Jian Zhang,
P. Fang,
Hui Zeng,
2015,
Cancer letters.
G. Sonpavde,
M. Galsky,
Liang Cheng,
2016,
Urologic oncology.
R. Figlin,
M. Amin,
B. Knudsen,
2017,
Scientific Reports.
Guofang Ding,
Fangjin Huang,
Y. Xu,
2014,
Molecules.
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Simon G. Coetzee,
Dennis J. Hazelett,
P. Nelson,
2018,
Nature Medicine.
M. Moasser,
W. Carter,
J. Lang,
2018,
Oncogene.